(Q44856428)

6 December 2017

1 reference

title

Clinical use of markers of neurohormonal activation in heart failure (English)

1 reference

6 December 2017

1 reference

Eulalia Roig Minguell

series ordinal

1

1 reference

6 December 2017

language of work or name

Spanish

0 references

publication date

1 April 2004

1 reference

Revista Española de Cardiología

6 December 2017

published in

1 reference

6 December 2017

volume

57

1 reference

6 December 2017

issue

4

1 reference

6 December 2017

page(s)

347-356

1 reference

Trends in hospitalization and mortality for heart failure in Spain, 1980-1993.

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

[Baseline characteristics and determinants of outcome in a patient population admitted for heart failure to a general hospital]

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

More ‘malignant’ than cancer? Five-year survival following a first admission for heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

Molecular and cellular mechanisms of myocardial failure

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

Plasma norepinephrine in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

Evidence for reduction of norepinephrine uptake sites in the failing human heart

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

Effect of long-term enalapril therapy on neurohormones in patients with left ventricular dysfunction. SOLVD Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD)

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

Prognostic value of cytokines and neurohormones in severe heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure: the Valsartan Heart Failure Trial (Val-HeFT).

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

Impact of beta-blocker treatment on the prognostic value of currently used risk predictors in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

Two-year time course and significance of neurohumoral activation in the Survival and Ventricular Enlargement (SAVE) Study

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy : the randomized evaluation of strategies for left ventricular dysfunction pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

Elevated plasma aldosterone levels despite complete inhibition of the vascular angiotensin-converting enzyme in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

1 reference

7 January 2021

Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

Value of cardiopulmonary exercise testing and big endothelin plasma levels to predict short-term prognosis of patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

Plasma endothelin-1 levels and clinical correlates in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

1 reference

7 January 2021

Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

Brain natriuretic peptide. Diagnostic value in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

B-type natriuretic peptide in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

B-type natriuretic peptide predicts sudden death in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

Pre-discharge, but not admission, levels of NT-proBNP predict adverse prognosis following acute LVF.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

Plasma adrenomedullin, a new independent predictor of prognosis in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

The role of tumor necrosis factor in the pathophysiology of heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

Load-dependent and -independent regulation of proinflammatory cytokine and cytokine receptor gene expression in the adult mammalian heart

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

Negative inotropic effects of cytokines on the heart mediated by nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

Elevated circulating levels of tumor necrosis factor in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

Prognostic value of serum cytokines in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

Plasma cytokine parameters and mortality in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

Effect of beta-blockers on circulating levels of inflammatory and anti-inflammatory cytokines in patients with dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

Serum interleukin-6 in congestive heart failure secondary to idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

The prognostic value of circulating soluble cell adhesion molecules in patients with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

Prognostic value of plasma soluble intercellular adhesion molecule-1 and endothelin-1 concentration in patients with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

Cytokine-induced nitric oxide production inhibits mitochondrial energy production and impairs contractile function in rat cardiac myocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

Plasma oxidized low-density lipoprotein as a prognostic predictor in patients with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

Clinical significance of elevated levels of cardiac troponin T in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977113-4

7 January 2021

10.1016/S0300-8932(04)77113-4

Identifiers

DOI

1 reference

6 December 2017

1 reference